Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Rituximab | Rituximab Inhibitor. Uses: Scientific use. Product Category: T9910. CAS No. 174722-31-7. |  |
| Rituximab | Rituximab is an anti-CD20 chimeric monoclonal antibody used for research of certain autoimmune diseases and cancer. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anti-Human CD20 type I, Chimeric Antibody. CAS No. 174722-31-7. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P9913. |  |
| Rituximab | Rituximab is an anti-CD20 monoclonal antibody used for the treatment of certain autoimmune diseases and hematological cancers such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, etc. Its binding to CD20, which exists on the surface of immune system B cells, leads to death of cells. Uses: The treatment of non-hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, etc. Synonyms: Immunoglobulin G1; Hsdb 7455; Hsdb-7455; Hsdb7455; Immunoglobulin G 1 (human-mouse monoclonal idec-C2B8 gamma1-chain anti-human antigen cd 20), disulfide with human-mouse monoclonal idec-C2B8 kappa-chain, dimer; Mab thera; Mabthera; Rituxan; Unii-4F4X42syq6; Retuxin. CAS No. 174722-31-7. Molecular formula: C6416H9874N1688O1987S44. Mole weight: 143859.7. |  |
| Rituximab (anti-CD20) | Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 174722-31-7. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P9913A. | |
| Idelalisib | Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL). Uses: The treatment of chronic lymphocytic leukemia (cll). Synonyms: Idelalisib; CAL101; CAL 101; CAL-101; GS1101; GS 1101; GS-1101, Idelalisib. Grades: > 95%. CAS No. 870281-82-6. Molecular formula: C22H18FN7O. Mole weight: 415.432. | |
| Polatuzumab | Polatuzumab is a monoclonal antibody directed against CD79b, which is ubiquitously expressed on the surface of malignant B cells. Polatuzumab can be used in the synthesis of polatuzumab vedotin, an ADC indicated in combination with bendamustine and a rituximab product for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). CAS No. 2279068-37-8. | |
| Truxima | Truxima is a bioanalogue of rituximab used for the treatment of all the indications of rituximab such as non-Hodgkin's lymphoma, chronic lymphocytic leukaemia (CLL), severe rheumatoid arthritis and granulomatosis with polyangiitis. Uses: All the indications of rituximab. | |
Our database is helping our users find suppliers everyday.
